REPORTS

Let’s Pullulate and Expand Your Business

Current Neurostimulation Market - Global Professional Analysis and Forecast to 2026

Nov 03, 2019  |  224 PAGES  |  REPORT CODE: CMM227290
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Current Neurostimulation market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 11.4% during the forecast period.

This report presents the market size and development trends by detailing the Current Neurostimulation market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Current Neurostimulation market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Current Neurostimulation industry and will help you to build a panoramic view of the industrial development.

Current Neurostimulation Market, By Type:

  • Deep brain stimulation (DBS)

  • Spinal cord stimulation (SCS)

  • Vagus nerve stimulation (VNS)

  • Sacral nerve stimulation (SNS)

Current Neurostimulation Market, By Application:

  • First Aid

  • Healthcare

Some of the leading players are as follows:

  • Neuropace

  • Neurosigma

  • Neuronetics

  • Cerebomed

  • Endostim

  • BioControl Medical

  • Boston Scientific

  • ANM Adaptive Neuromodulation

  • Cyberonics

  • EnteroMedics

  • Medtronic

  • Magstim

  • Nevro

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Current Neurostimulation Market: Technology Type Analysis

  • 4.1 Current Neurostimulation Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Current Neurostimulation Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Deep brain stimulation (DBS)

    • 4.3.2 Spinal cord stimulation (SCS)

    • 4.3.3 Vagus nerve stimulation (VNS)

    • 4.3.4 Sacral nerve stimulation (SNS)

5 Current Neurostimulation Market: Product Analysis

  • 5.1 Current Neurostimulation Product Market Share Analysis, 2018 & 2026

  • 5.2 Current Neurostimulation Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Current Neurostimulation Market: Application Analysis

  • 6.1 Current Neurostimulation Application Market Share Analysis, 2018 & 2026

  • 6.2 Current Neurostimulation Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 First Aid

    • 6.3.2 Healthcare

7 Current Neurostimulation Market: Regional Analysis

  • 7.1 Current Neurostimulation Regional Market Share Analysis, 2018 & 2026

  • 7.2 Current Neurostimulation Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Neuropace

    • 9.1.1 Neuropace Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Neurosigma

    • 9.2.1 Neurosigma Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Neuronetics

    • 9.3.1 Neuronetics Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Cerebomed

    • 9.4.1 Cerebomed Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Endostim

    • 9.5.1 Endostim Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 BioControl Medical

    • 9.6.1 BioControl Medical Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Boston Scientific

    • 9.7.1 Boston Scientific Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 ANM Adaptive Neuromodulation

    • 9.8.1 ANM Adaptive Neuromodulation Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Cyberonics

    • 9.9.1 Cyberonics Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 EnteroMedics

    • 9.10.1 EnteroMedics Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Medtronic

    • 9.11.1 Medtronic Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Magstim

    • 9.12.1 Magstim Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Nevro

    • 9.13.1 Nevro Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

 

The List of Tables and Figures (Totals 70 Figures and 157 Tables)

  • Figure Deep brain stimulation (DBS) Current Neurostimulation market, 2015 - 2026 (USD Million)

  • Figure Spinal cord stimulation (SCS) Current Neurostimulation market, 2015 - 2026 (USD Million)

  • Figure Vagus nerve stimulation (VNS) Current Neurostimulation market, 2015 - 2026 (USD Million)

  • Figure Sacral nerve stimulation (SNS) Current Neurostimulation market, 2015 - 2026 (USD Million)

  • Figure First Aid market, 2015 - 2026 (USD Million)

  • Figure Healthcare market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Current Neurostimulation market, by country, 2015 - 2026 (USD Million)

  • Table North America Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table North America Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table North America Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table Canada Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table Canada Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table Europe Current Neurostimulation market, by country, 2015 - 2026 (USD Million)

  • Table Europe Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table Europe Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table Europe Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table Germany Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table Germany Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table France Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table France Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table Italy Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table Italy Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table Spain Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table Spain Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Current Neurostimulation market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table China Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table China Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table Japan Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table Japan Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table India Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table India Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Current Neurostimulation market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table MEA Current Neurostimulation market, by country, 2015 - 2026 (USD Million)

  • Table MEA Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table MEA Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table MEA Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Current Neurostimulation market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Current Neurostimulation market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Current Neurostimulation market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Neuropace Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Neurosigma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Neuronetics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cerebomed Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Endostim Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table BioControl Medical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Boston Scientific Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ANM Adaptive Neuromodulation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cyberonics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table EnteroMedics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Medtronic Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Magstim Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Nevro Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top